|
The press releases
and information stored here shall not constitute an offer to sell or a solicitation
of an offer to buy any securities of the Company. To
the extent that statements in the press releases and
information stored here are
not strictly historical, including statements as to
the Company's business strategy, outlook, objectives,
plans, intentions, goals, future financial conditions,
future collaboration agreements, the success of the
Company's product development, or otherwise as to future
events, such statements are forward-looking, and are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. The forward-looking
statements contained in these releases are subject to
certain risks and uncertainties that could cause actual
results to differ materially from the statements made. Among
the factors which could affect the Company's actual
results and could cause results to differ from
those contained in the forward-looking statements contained
herein are the risk that financial conditions may change,
the risk that the Company will not be able to raise
additional capital or enter into additional collaboration
agreements, risks relating to the progress of the Company's
research and development and the development of competing
therapies and/or technologies by other companies.
Those associated risks and others are further described
in the Company's periodic filings with the Securities
and Exchange Commission, including the most recent reports
on Forms 10-KSB, 8-K, 10-QSB and 10-Q, and amendments
thereto. |
